Intercept Pharmaceuticals
Pre-clinicalAt Intercept, our focus is to develop and deliver novel medicines for those living with rare and serious liver diseases.
Founded
2002
Focus
Small Molecules
About
At Intercept, our focus is to develop and deliver novel medicines for those living with rare and serious liver diseases.
Funding History
3Total raised: $151M
IPO$86MUndisclosedOct 11, 2012
Series B$40MUndisclosedJun 15, 2005
Series A$25MUndisclosedJun 15, 2002
Company Info
TypePrivate
Founded2002
LocationMorristown, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile